Bethesda, Maryland 20892


This study will allow National Eye Institute (NEI) doctors the opportunity to examine people with eye disease, whether the diagnosis is known or not, to determine if they are eligible for other NEI research studies. No treatment is offered in this study. People of all ages with various eye conditions, including genetic conditions, eye movement disorders, inflammatory eye diseases, retinal diseases and external eye diseases, may be eligible for this study. Participants undergo various tests and procedures to diagnose or evaluate their eye disease. The procedures may include the following: - Personal and family medical history - Physical examination and blood tests, including genetic testing. - Eye examination with dilation to measure visual acuity and eye pressure and to examine the front and back parts of the eye. - Questionnaire about vision and daily activities. - Conjunctival swab or lacrimal bland biopsy, or both: A sample of cells from the eyes is collected by swabbing the surface of the eye or by surgically removing a small sample of the surface of the eye or tear gland. - Electroretinogram to examine retinal function: The subject sits in the dark with his or her eyes patched for 30 minutes. The patches are removed, the surface of the eyes is numbed, and contact lenses that can sense signals from the retina are placed on the eyes. The subject then watches flashing lights. - Fluorescein angiography to examine the blood vessels in the eye: A dye is injected into a vein in the arm. The dye travels through the veins to the blood vessels in the eyes. A camera takes pictures of the dye as it flows through the blood vessels. - Optical coherence tomography to measure retinal thickness: A machine used to examine the eyes produces cross-sectional pictures of the retina. - Microperimetry to test how sensitive different parts of the retina are to changing levels of light. The subject sits in front of a computer and presses a button when he or she sees a light on the screen. - Oculography to record eye movements: Eye movements are measured by contact lenses or goggles that the subject wears while watching a series of spots on a computer screen.

Study summary:

This protocol is designed for the screening of potential research participants with or without a defined diagnosis. This protocol will serve as a point of entry for individuals who may be eligible and wish to participate in the National Eye Institute (NEI) clinical research studies. Participants referred or self-referred for a second opinion will be also screened and evaluated during the screening process to determine whether they are suitable participants for any of the ongoing NEI research studies. The screening process will include past and current medical history, a physical examination, routine diagnostic procedures and required testing as needed to help determine a participant s eligibility for research participation and diagnosis. Other routine diagnostic procedures and tests may also be done to help determine a participant s eligibility. Once the screening process is complete, participants will be informed of their options to participate in one or more of the NEI s current clinical research protocols. If no suitable research protocol for their participation is identified, recommendations for other treatment options may be given to the individual, their primary provider or referring physician. This protocol s secondary aim is to collect and store human biospecimens and health information for basic science laboratory research. Basic science research may be both hypothesis generating and/or hypothesis testing. Biospecimen samples such as blood, body fluid (e.g., urine), genomic, and tissue (e.g., skin or hair) may be collected from affected or unaffected adult participants as well as affected pediatric participants; biospecimen samples can be collected at the time of screening or anytime thereafter. These samples may be used for basic science laboratory research or stored and used in future research studies. Through such studies, the investigators hope to find possible new ways to detect, treat and possibly even prevent or cure ophthalmological diseases. Biospecimen sample collection will be voluntary for all participants, and participants will be consented using the Screening and Biospecimen Collection consent prior to their participation in this arm of the study.


- INCLUSION CRITERIA: Participants will be able to enroll if they: - Have a diagnosed ocular disease/disorder; OR - Potentially have an unusual, interesting, or unknown ocular condition that requires the establishment of a diagnosis; OR - Potentially participate as a disease-free control participant in an NEI clinical research study; OR - Are an unaffected first-degree relative of a participant with either a diagnosed or undiagnosed ocular disorder; AND - Have the ability to understand and sign an informed consent OR if they are minor children have a legal parent/guardian with the ability to do the same. - Adults with impaired capacity to consent must have a legally authorized representative that is able to provide informed consent. EXCLUSION CRITERIA: Participants will be unable to enroll if they: -Are unwilling or unable to cooperate with the study procedures.



Primary Contact:

Principal Investigator
Awilda V Holland
National Eye Institute (NEI)

Awilda (Wendy) Holland, R.N.
Phone: (301) 435-1831

Backup Contact:

Awilda V Holland
Phone: (301) 435-7831

Location Contact:

Bethesda, Maryland 20892
United States

For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
Phone: 800-411-1222

Site Status: Recruiting

Data Source:

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.